Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
128.4%
-
Total 13F principal
-
$395,023,539
-
Principal change
-
-$14,826,330
-
Total reported market value
-
$508,167,000
-
Number of holders
-
42
-
Value change
-
-$19,044,296
-
Number of buys
-
15
-
Number of sells
-
21
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q3 2014
As of 30 Sep 2014,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
42 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$395,023,539
in principal (par value) of the bond.
The largest 10 bondholders included
ZAZOVE ASSOCIATES LLC, Lombard Odier Asset Management (Europe) Ltd, MACKAY SHIELDS LLC, CREDIT SUISSE AG/, Invesco Ltd., Thrivent Financial for Lutherans, VICTORY CAPITAL MANAGEMENT INC, BNP Paribas Investment Partners S.A., INCOME RESEARCH & MANAGEMENT, and Calamos Advisors LLC.
This page lists
42
institutional bondholders reporting positions
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.